Healthcare News Options
Novo CEO pressed by Senate to chop rates of being overweight, diabetic issues prescription drugs CEO Lars Fruergaard Jørgensen instructed lawmakers the company would look at new talks with insurers with regard to the record selling prices of Wegovy and copyright when they pledge to keep the medicines on their own formularies.Sanders quickly condem